AAAAAA
Results: 1-25/80
Authors:
Gozuacik, D
Murakami, Y
Saigo, K
Chami, M
Mugnier, C
Lagorce, D
Okanoue, T
Urashima, T
Brechot, C
Paterlini-Brechot, P
Citation: D. Gozuacik et al., Identification of human cancer-related genes by naturally occurring Hepatitis B Virus DNA tagging, ONCOGENE, 20(43), 2001, pp. 6233-6240
Authors:
Delhem, N
Sabile, A
Gajardo, R
Podevin, P
Abadie, A
Blaton, MA
Kremsdorf, D
Beretta, L
Brechot, C
Citation: N. Delhem et al., Activation of the interferon-inducible protein kinase PKR by Hepatocellular carcinoma derived-Hepatitis C virus core protein, ONCOGENE, 20(41), 2001, pp. 5836-5845
Authors:
Huo, TI
Wang, XW
Forgues, M
Wu, CG
Spillare, EA
Giannini, C
Brechot, C
Harris, CC
Citation: Ti. Huo et al., Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis, ONCOGENE, 20(28), 2001, pp. 3620-3628
Authors:
Gerolami, R
Uch, R
Cardoso, J
Bagnis, C
Mannoni, P
Brechot, C
Citation: R. Gerolami et al., Gene therapy for hepatocellular carcinoma. From the idea to clinical trials, GASTRO CL B, 25(3), 2001, pp. 273-286
Authors:
Brechot, C
Thiers, V
Kremsdorf, D
Nalpas, B
Pol, S
Paterlini-Brechot, P
Citation: C. Brechot et al., Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: Clinically significant or purely "occult"?, HEPATOLOGY, 34(1), 2001, pp. 194-203
Authors:
Podevin, P
Sabile, A
Gajardo, R
Delhem, N
Abadie, A
Lozach, PY
Beretta, L
Brechot, C
Citation: P. Podevin et al., Expression of hepatitis C virus NS5A natural mutants in a hepatocytic cellline inhibits the antiviral effect of interferon in a PKR-independent manner, HEPATOLOGY, 33(6), 2001, pp. 1503-1511
Authors:
Bottazzi, ME
Buzzai, M
Zhu, XY
Desdouets, C
Brechot, C
Assoian, RK
Citation: Me. Bottazzi et al., Distinct effects of mitogens and the actin cytoskeleton on CREB and pocketprotein phosphorylation control the extent and timing of cyclin A promoteractivity, MOL CELL B, 21(22), 2001, pp. 7607-7616
Authors:
Michel, ML
Pol, S
Brechot, C
Tiollais, P
Citation: Ml. Michel et al., Immunotherapy of chronic hepatitis B by anti HBV vaccine: from present to future, VACCINE, 19(17-19), 2001, pp. 2395-2399
Authors:
Nalpas, B
Martin, S
Fontaine, H
Fabbro-Peray, P
Brechot, C
Pol, S
Citation: B. Nalpas et al., Impact of medical recommendations on alcohol consumption in HCV positive patients, J HEPATOL, 35(2), 2001, pp. 312-313
Authors:
Pol, S
Nalpas, B
Driss, F
Michel, ML
Tiollais, P
Denis, J
Brechot, C
Citation: S. Pol et al., Efficacy and limitations of a specific immunotherapy in chronic hepatitis B, J HEPATOL, 34(6), 2001, pp. 917-921
Authors:
Fontaine, H
Nalpas, B
Poulet, B
Carnot, F
Zylberberg, H
Brechot, C
Pol, S
Citation: H. Fontaine et al., Hepatitis activity index is a key factor in determining the natural history of chronic hepatitis C, HUMAN PATH, 32(9), 2001, pp. 904-909
Authors:
Gordien, E
Rosmorduc, O
Peltekian, C
Garreau, F
Brechot, C
Kremsdorf, D
Citation: E. Gordien et al., Inhibition of hepatitis B virus replication by the interferon-inducible MxA protein, J VIROLOGY, 75(6), 2001, pp. 2684-2691
Authors:
De Beeck, AO
Sobczak-Thepot, J
Sirma, H
Bourgain, F
Brechot, C
Caillet-Fauquet, P
Citation: Ao. De Beeck et al., NS1-and minute virus of mice-induced cell cycle arrest: Involvement of p53and p21(cip1), J VIROLOGY, 75(22), 2001, pp. 11071-11078
Authors:
Soussan, P
Pol, S
Garreau, F
Brechot, C
Kremsdorf, D
Citation: P. Soussan et al., Vaccination of chronic hepatitis B virus carriers with preS2/S envelope protein is not associated with the emergence of envelope escape mutants, J GEN VIROL, 82, 2001, pp. 367-371
Authors:
Chami, M
Gozuacik, D
Lagorce, D
Brini, M
Falson, P
Peaucellier, G
Pinton, P
Lecoeur, H
Gougeon, ML
le Maire, M
Rizzuto, R
Brechot, C
Paterlini-Brechot, P
Citation: M. Chami et al., SERCA1 truncated proteins unable to pump calcium reduce the endoplasmic reticulum calcium concentration and induce apoptosis, J CELL BIOL, 153(6), 2001, pp. 1301-1313
Authors:
Faivre, J
Frank-Vaillant, M
Poulhe, R
Mouly, H
Brechot, C
Sobczak-Thepot, J
Jessus, C
Citation: J. Faivre et al., Membrane-anchored cyclin A2 triggers Cdc2 activation in Xenopus oocyte, FEBS LETTER, 506(3), 2001, pp. 243-248
Authors:
Tu, H
Bonura, C
Giannini, C
Mouly, H
Soussan, P
Kew, M
Paterlini-Brechot, P
Brechot, C
Kremsdorf, D
Citation: H. Tu et al., Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues, CANCER RES, 61(21), 2001, pp. 7803-7810
Authors:
Kirk, GD
Camus-Randon, AM
Mendy, M
Goedert, JJ
Merle, P
Trepo, C
Brechot, C
Hainaut, P
Montesano, R
Citation: Gd. Kirk et al., Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from the Gambia, J NAT CANC, 92(2), 2000, pp. 148-153
Authors:
Brechot, C
Citation: C. Brechot, Hepatocellular carcinoma - Introduction, SEM CANC B, 10(3), 2000, pp. 159-159
Authors:
Brechot, C
Gozuacik, D
Murakami, Y
Paterlini-Brechot, P
Citation: C. Brechot et al., Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC), SEM CANC B, 10(3), 2000, pp. 211-231
Authors:
Paterlini-Brechot, P
Vona, G
Brechot, C
Citation: P. Paterlini-brechot et al., Circulating tumorous cells in patients with hepatocellular carcinoma. Clinical impact and future directions, SEM CANC B, 10(3), 2000, pp. 241-249
Authors:
Hegenbarth, S
Gerolami, R
Protzer, U
Tran, PL
Brechot, C
Gerken, G
Knolle, PA
Citation: S. Hegenbarth et al., Liver sinusoidal endothelial cells are not permissive for adenovirus type 5, HUM GENE TH, 11(3), 2000, pp. 481-486
Hepatitis B virus-related insertional mutagenesis implicates SERCA1 gene in the control of apoptosis
Authors:
Chami, M
Gozuacik, D
Saigo, K
Capiod, T
Falson, P
Lecoeur, H
Urashima, T
Beckmann, J
Gougeon, ML
Claret, M
le Maire, M
Brechot, C
Paterlini-Brechot, P
Citation: M. Chami et al., Hepatitis B virus-related insertional mutagenesis implicates SERCA1 gene in the control of apoptosis, ONCOGENE, 19(25), 2000, pp. 2877-2886
Authors:
Gerolami, R
Uch, R
Jordier, F
Chapel, S
Bagnis, C
Brechot, C
Mannoni, P
Citation: R. Gerolami et al., Gene transfer to hepatocellular carcinoma: Transduction efficacy and transgene expression kinetics by using retroviral and lentiviral vectors, CANC GENE T, 7(9), 2000, pp. 1286-1292
Authors:
Bilbao, R
Gerolami, R
Bralet, MP
Qian, C
Tran, PL
Tennant, B
Prieto, J
Brechot, C
Citation: R. Bilbao et al., Transduction efficacy, antitumoral effect, and toxicity of adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir therapy of hepatocellular carcinoma: The woodchuck animal model, CANC GENE T, 7(5), 2000, pp. 657-662